Investor Day to be held in New York on March 19 at 9 am. Webcast LinkLight Up your Portfolio with Spark:Easily identify stocks' risks and ...

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

At a meeting with analysts and investors at its 2025 Investor Day, members of the leadership team of Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will discuss ...

Shares of Quest Diagnostics (NYSE: NYSE:DGX) tumbled 4.75% today after the company provided long-term guidance that failed to meet investor expectations. Despite reaffirming its full-year 2025 ...

Quest Diagnostics reported revenues of $2.49 billion ... toward future profitability amidst evolving market conditions. Investors should monitor the company’s capability to integrate recent ...

Quest Diagnostics saw robust growth in earnings ... confidence in the business's core strength and strategic initiatives. Investors should closely monitor Quest's cost management strategies ...

Shares of Quest Diagnostics Inc. DGX shed 1.39% to $173.12 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to 5,614. ...

and SECAUCUS, N.J., March 18, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE ... to both investment professionals and individual investors. These products and services are usually sold through ...

Value investors will likely look at more than just these metrics, but the above data helps show that Quest Diagnostics is likely undervalued currently. And when considering the strength of its ...